INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Accessibility

More about accessibility

Trouble using our website?
Contact us

Text logo ERN-EYE Tools
CPMS REDgistry Elearning Members area
Accessibility

Katairo

In this page

Clinical Trial

2018-001496-20 Recruiting, Active
Katairo

Clinical trials for A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral Soraprazan in Stargardt Phase 2, disease SMR-3438, Katairo

Phase 2
Interventional

Disease

Disease type

Stargardt Disease

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

14/05/2019

Inclusion criteria :

More

Exclusion criteria :

More

Members involved

Others investigators

Pr Frank Holz

Representative

Germany

See more

ERN EYE member investigating site

HCP : Principal investigators

More